Pre-clinical development of a novel class of broad-spectrum natural product antivirals
Pre-clinical development of a novel class of broad-spectrum natural product antivirals
批准号:
480228
负责人:
Jean François
金额:
$57.4万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2026-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Emerging human viruses such as SARS-CoV-2 (cause of COVID-19), influenza A virus (acute respiratory infection), and Zika virus (microcephaly and other congenital malformations), have had an enormous impact on human health. The World Health Organization (
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-clinical development of broad-spectrum antiviral strategies against human respiratory viruses of pandemic concern
-
批准号:462582
-
项目类别:Operating Grants
-
资助金额:$68.88万
-
财政年份:2022
-
负责人:Jean François
-
依托单位:
Development and application of mass-spectrometry-based multiplexing assays for detecting Zika virus and uncovering novel anti-flaviviral strategies
-
批准号:366553
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2016
-
负责人:Jean François
-
依托单位:
Molecular and cellular studies of novel subtilase-directed secretory pathway serpins
-
批准号:178316
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2008
-
负责人:Jean François
-
依托单位:
海外基金